EE304 IDegAsp Treatment Was Associated with Reduced Healthcare Resource Utilization in Adults with Type 2 Diabetes: A Real-World Study

A Alturaiki,M Al-Suwairi,S Akhtar,A Basse,M D’Emden,A Kok,J Garcia Uranga,J Snyman,G Fulcher

doi:10.1016/j.jval.2022.04.549

EE304 IDegAsp Treatment Was Associated with Reduced Healthcare Resource Utilization in Adults with Type 2 Diabetes: A Real-World Study

A Alturaiki, M Al-Suwairi + Show 7 more

Open Access

https://doi.org/10.1016/j.jval.2022.04.549

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: Jun 25, 2022
License type: publisher-specific-oa

Affiliation: National Guard Health Affairs, Novo Nordisk (Switzerland), Royal Brisbane and Women's Hospital, Netcare Unitas Hospital, University of Sydney

#Reduced Healthcare Resource Utilization #Treatment Was + Show 7 more

Abstract
Full-Text PDF
Similar Papers

Abstract

To evaluate the impact of insulin degludec/insulin aspart (IDegAsp) treatment on healthcare resource utilization (HRU) in adults with type 2 diabetes (T2D).

Full Text